(Abst.) Neutropenia w/fatal outcome in MS patient 23 days after alemtuzumab infusion on: July 23, 2018, 07:49:08 pm #1 From Multiple Sclerosis and Related Disorders (July 2018), "Neutropenia with fatal outcome in a multiple sclerosis patient 23 days after alemtuzumab infusion":https://www.msard-journal.com/article/S2211-0348(18)30133-0/abstract Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
